A personalised vaccine against melanoma can more than double the survival
rate for patients with the advanced form of this skin cancer. Doctors at
Jefferson Medical College in Philadelphia create customised vaccines from
patients’ own cancer cells by inactivating them and altering their surface
proteins with dinitrophenol. Five-year survival rates in 214 patients with
advanced disease increased from around 20 per cent to 50 per cent and a
randomised phase III trial of 400 patients across the US is planned.
To continue reading, today with our introductory offers
Advertisement
More from ¿ìè¶ÌÊÓƵ
Explore the latest news, articles and features
Popular articles
Trending ¿ìè¶ÌÊÓƵ articles
1
The best new science-fiction books of June 2026
2
Pancreatic cancer halted by virus injection in three patients
3
Glaciers in the 'roof of the world' have suddenly started melting
4
Does gravity create reality? A shocking path to a theory of everything
5
Start-ups are racing to revolutionise mathematics with AI
6
Aim high but don't shoot for the moon, mathematicians advise
7
Professor Daisy Fancourt on the life-changing power of the arts
8
Mirror life: ¿ìè¶ÌÊÓƵs clash over threat of lab-engineered bacteria
9
Where did the laws of physics come from? I think I've found the answer
10
We may finally know why gold stays so shiny
